Menu
Search
|

Menu

Close
X

Avinger Inc AVGR.OQ (NASDAQ Stock Exchange Capital Market)

1.13 USD
+0.00 (+0.00%)
As of Sep 13
Previous Close 1.13
Open 1.13
Volume 69,444
3m Avg Volume 64,163
Today’s High 1.14
Today’s Low 1.08
52 Week High 15.50
52 Week Low 1.05
Shares Outstanding (mil) 23.91
Market Capitalization (mil) 7.83
Forward P/E --
Dividend (Yield %) -- ( -- )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.50 Mean rating from 2 analysts

KEY STATS

Revenue (mm, USD)
FY19
4
FY18
8
FY17
10
FY16
19
EPS (USD)
FY19
-2.270
FY18
-98.299
FY17
-769.431
FY16
-1,460.652
*Note: Units in Millions of U.S. Dollars
**Note: Units in U.S. Dollars

KEY RATIOS

Price to Earnings (TTM)
vs sector
--
32.66
Price to Sales (TTM)
vs sector
0.49
7.91
Price to Book (MRQ)
vs sector
--
5.38
Price to Cash Flow (TTM)
vs sector
--
24.36
Total Debt to Equity (MRQ)
vs sector
--
14.55
LT Debt to Equity (MRQ)
vs sector
--
10.20
Return on Investment (TTM)
vs sector
-918.27
14.48
Return on Equity (TTM)
vs sector
--
15.78

EXECUTIVE LEADERSHIP

James Cullen
Non-Executive Chairman of the Board, Since 2017
Salary: --
Bonus: --
Jeffrey Soinski
President, Chief Executive Officer, Director, Since 2014
Salary: $390,000.00
Bonus: --
Mark Weinswig
Chief Financial Officer, Since 2018
Salary: --
Bonus: --
Himanshu Patel
Chief Technology Officer, Since 2013
Salary: --
Bonus: --
Jaafer Golzar
Chief Medical Officer, Since 2018
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Advanced Medical Equipment & Technology
Address:

400 Chesapeake Dr
REDWOOD CITY   CA   94063-4739

Phone: +1650.3632400
Site: avinger.com/

Avinger, Inc. is a commercial-stage medical device company. The Company designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease (PAD). The Company focuses on introducing products based on its lumivascular platform, which is an intravascular image-guided system. The Company manufactures and sells a suite of products in the United States and certain European markets. The Company's products include Lightbox imaging console, as well as its Wildcat, Kittycat and the Ocelot family of catheters, which are designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO). The lumivascular platform offers real-time visualization of the inside of the artery during PAD treatment. The lumivascular platform consists of a capital component Lightbox and a range of disposable catheter products, including Ocelot, Ocelot PIXL, Ocelot MVRX and Pantheris.

SPONSORED STORIES